NO914999D0 - Korte peptider med insulinvirkning - Google Patents

Korte peptider med insulinvirkning

Info

Publication number
NO914999D0
NO914999D0 NO914999A NO914999A NO914999D0 NO 914999 D0 NO914999 D0 NO 914999D0 NO 914999 A NO914999 A NO 914999A NO 914999 A NO914999 A NO 914999A NO 914999 D0 NO914999 D0 NO 914999D0
Authority
NO
Norway
Prior art keywords
amino acid
short peptides
covalent bond
insulin effect
formula
Prior art date
Application number
NO914999A
Other languages
English (en)
Other versions
NO308951B1 (no
NO914999L (no
Inventor
Stefan Muellner
Wolfgang Koenig
Guenter Mueller
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO914999D0 publication Critical patent/NO914999D0/no
Publication of NO914999L publication Critical patent/NO914999L/no
Publication of NO308951B1 publication Critical patent/NO308951B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO914999A 1990-12-19 1991-12-18 AnalogifremgangsmÕte for fremstilling av terapeutisk aktive korte peptider med insulinvirkning NO308951B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4040574 1990-12-19

Publications (3)

Publication Number Publication Date
NO914999D0 true NO914999D0 (no) 1991-12-18
NO914999L NO914999L (no) 1992-06-22
NO308951B1 NO308951B1 (no) 2000-11-20

Family

ID=6420676

Family Applications (1)

Application Number Title Priority Date Filing Date
NO914999A NO308951B1 (no) 1990-12-19 1991-12-18 AnalogifremgangsmÕte for fremstilling av terapeutisk aktive korte peptider med insulinvirkning

Country Status (24)

Country Link
US (1) US5461035A (no)
EP (1) EP0491361B1 (no)
JP (2) JP3378588B2 (no)
KR (1) KR100237948B1 (no)
AT (1) ATE177753T1 (no)
AU (1) AU643349B2 (no)
CA (1) CA2058020C (no)
CZ (1) CZ284568B6 (no)
DE (1) DE59109109D1 (no)
DK (1) DK0491361T3 (no)
ES (1) ES2130130T3 (no)
FI (1) FI105816B (no)
GR (1) GR3030510T3 (no)
HR (1) HRP940839B1 (no)
HU (1) HU222493B1 (no)
IE (1) IE914408A1 (no)
IL (1) IL100400A (no)
NO (1) NO308951B1 (no)
NZ (1) NZ241029A (no)
PT (1) PT99850B (no)
SK (2) SK282361B6 (no)
TW (1) TW227004B (no)
YU (1) YU189891A (no)
ZA (1) ZA919938B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE184611T1 (de) * 1991-11-29 1999-10-15 Hoechst Ag Peptide mit insulinartiger wirkung
SE0002716L (sv) * 2000-07-18 2002-01-19 Lars Wahlberg Komposition mot insekter
DE60204847T2 (de) * 2001-01-15 2006-05-11 Société de Technologie Michelin Formgebungstrommel für die reifenherstellung
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
KR101909052B1 (ko) * 2017-02-09 2018-10-17 강원대학교산학협력단 인슐린의 a 사슬로부터 유래된 펩타이드 단편 및 이를 포함하는 당뇨병 또는 당뇨병성 창상의 예방 또는 치료용 약학 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2740406A1 (de) * 1977-09-08 1979-03-22 Hoechst Ag Teilgeschuetzte human-insulin-a-kette und verfahren zu ihrer herstellung
DE2801175A1 (de) * 1978-01-12 1979-07-19 Hoechst Ag Verfahren zur herstellung cysteinhaltiger peptide
DD147942A1 (de) * 1979-08-20 1981-04-29 Guenter Losse Verfahren zur herstellung von cystin-peptiden mit insulinaehnlicher wirkung
FR2525592B1 (no) * 1982-04-26 1984-09-14 Pasteur Institut

Also Published As

Publication number Publication date
GR3030510T3 (en) 1999-10-29
KR920012115A (ko) 1992-07-25
ZA919938B (en) 1992-09-30
EP0491361B1 (de) 1999-03-17
NO308951B1 (no) 2000-11-20
US5461035A (en) 1995-10-24
IL100400A (en) 1998-01-04
HU222493B1 (hu) 2003-07-28
AU643349B2 (en) 1993-11-11
DE59109109D1 (de) 1999-04-22
TW227004B (no) 1994-07-21
FI915933A (fi) 1992-06-20
AU8982591A (en) 1992-06-25
HU914009D0 (en) 1992-03-30
PT99850B (pt) 1999-06-30
NZ241029A (en) 1993-01-27
HUT59697A (en) 1992-06-29
HRP940839B1 (en) 2000-02-29
SK282360B6 (sk) 2002-01-07
YU189891A (sh) 1995-10-03
KR100237948B1 (ko) 2000-01-15
IL100400A0 (en) 1992-09-06
IE914408A1 (en) 1992-07-01
CA2058020C (en) 2003-10-28
CA2058020A1 (en) 1992-06-20
JP2003176237A (ja) 2003-06-24
ATE177753T1 (de) 1999-04-15
EP0491361A3 (en) 1993-11-24
DK0491361T3 (da) 1999-10-11
PT99850A (pt) 1992-11-30
FI105816B (fi) 2000-10-13
JPH04295496A (ja) 1992-10-20
SK282361B6 (sk) 2002-01-07
CZ284568B6 (cs) 1999-01-13
JP3378588B2 (ja) 2003-02-17
FI915933A0 (fi) 1991-12-17
NO914999L (no) 1992-06-22
ES2130130T3 (es) 1999-07-01
JP3802863B2 (ja) 2006-07-26
EP0491361A2 (de) 1992-06-24
HRP940839A2 (en) 1997-06-30
CS387991A3 (en) 1992-07-15

Similar Documents

Publication Publication Date Title
AU1563588A (en) Pasteurizable, freeze-driable hemoglobin-based blood substitute
DK0397420T3 (da) Enzymatisk fjernelse af en aminoterminal proteinsekvens
DE69033040D1 (de) Verfahren zur Herstellung von biologisch aktivem Protein (z.B. TGF)
DE69533556D1 (de) N-terminal modifizierte Polypeptide, und Herstellungsprozess
NO911787D0 (no) Peptidaminer samt fremgangsmaate for fremstilling derav.
DK0711305T3 (da) Protegriner
ATE213499T1 (de) Peptidanaloge des menschlichen, basischen myelinproteins mit substitution an position 91 zur behandlung der multiplen sklerose
NO923252D0 (no) Fosfoinositolglykan-peptid med insulinlignende virkning
ATE130312T1 (de) Polypeptid mit sich wiederholenden zelladhäsiven hauptsequenzen.
FI892185A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten peptidiyhdisteiden valmistamiseksi
ATE185148T1 (de) Lipopeptide, t-cytotoxische lymphocyte aktivierend, und deren verwendung als vakzine
NO914999D0 (no) Korte peptider med insulinvirkning
ATE403726T1 (de) Cytokin-proteinfamilie
EP0326490A3 (en) Synthetic peptides and mixtures thereof for detecting hiv antibodies
KR920012114A (ko) 사람 면역결핍 바이러스(HIV)의 그룹-특이 항원(gaa)의 선택된 펩타이드, 이의 제법 및 용도
ATE83381T1 (de) Verwendung von rekombiniertem menschlichem alpha- interferon zur herstellung eines arzneimittels zur behandlung des aids-virus.
ATE124264T1 (de) Verwendung eines polypeptids mit humaner interleukin-2 aktivität zur herstellung pharmazeutischer zusammensetzungen zur behandlung von pneumothoraxen.
SE7706567L (sv) Biologiskt aktiva peptider

Legal Events

Date Code Title Description
MK1K Patent expired